Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [916]

The value of cancer care in low-resource settings

Dr Bishal Gyawali - Queen's University, Kingston, Canada

The value of cancer care in low-resource settings ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

Where have we got to with cancer treatment?

Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology...

Where have we got to with cancer treatment? ( Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands )

Immunotherapy for NSCLC: Recent advances and future directions

Prof Neal Ready - Duke University School of Medicine, Durham, USA

Immunotherapy for NSCLC: Recent advances and future directions ( Prof Neal Ready - Duke University School of Medicine, Durham, USA )

Immunotherapy and targeted agents for elderly lung cancer patients

Dr Lore Decoster - University Hospital Brussels, Brussels, Belgium

Immunotherapy and targeted agents for elderly lung cancer patients ( Dr Lore Decoster - University Hospital Brussels, Brussels, Belgium )

Challenges in treating elderly lung cancer patients

Prof Mike Jaklitsch - Harvard Medical School, Boston, USA

Challenges in treating elderly lung cancer patients ( Prof Mike Jaklitsch - Harvard Medical School, Boston, USA )

PROMISE-meso trial results: Pembrolizumab vs chemotherapy for advanced pleural...

Prof Sanjay Popat - The Royal Marsden Hospital, London, UK

PROMISE-meso trial results: Pembrolizumab vs chemotherapy for advanced pleural mesothelioma ( Prof Sanjay Popat - The Royal Marsden Hospital, London, UK )

Checkmate 227: Final analysis for the non small cell lung cancer trial

Prof Sanjay Popat - The Royal Marsden Hospital, London, UK

Checkmate 227: Final analysis for the non small cell lung cancer trial ( Prof Sanjay Popat - The Royal Marsden Hospital, London, UK )

Highlights from ESMO 2019

Prof Josep Tabernero - ESMO President

Highlights from ESMO 2019 ( Prof Josep Tabernero - ESMO President )

Pembrolizumab plus platinum-based chemotherapy for metastatic NSCLC

Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain

Pembrolizumab plus platinum-based chemotherapy for metastatic NSCLC ( Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain )

AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours

Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA

AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours ( Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA )

Blood first assay screening in patients with ALK positive NSCLC

Prof Shirish Gadgeel - University of Michigan, Ann Arbor, USA

Blood first assay screening in patients with ALK positive NSCLC ( Prof Shirish Gadgeel - University of Michigan, Ann Arbor, USA )

Holistic management of patients with ALK-positive NSCLC

Rachel Thomas and Jackie Fenemore

Holistic management of patients with ALK-positive NSCLC ( Rachel Thomas and Jackie Fenemore )

More from ecancer